Epidemiology and Management of Pediatric Group A Streptococcal Pneumonia With Parapneumonic Effusion: An Observational Study

Emily A. Lees,Thomas C. Williams,Robin Marlow,Felicity Fitzgerald,Christine Jones,Hermione Lyall,Alasdair Bamford,Louisa Pollock,Andrew Smith,Theresa Lamagni,Alison Kent,Elizabeth Whittaker,for the Group A Streptococcal Disease Consortium
DOI: https://doi.org/10.1097/inf.0000000000004418
2024-08-23
The Pediatric Infectious Disease Journal
Abstract:Streptococcus pyogenes (group A streptococcus, or GAS) is responsible for a broad spectrum of clinical diseases. This includes superficial, invasive group A streptococcal (iGAS) and postinfectious disease syndromes and is an important cause of morbidity and mortality in children globally. 1 , 2 There are over 200 ' emm ' strains of GAS identified to date. In the United Kingdom, a sublineage of emm1 (M1 UK ) with increased toxigenicity was identified in 2015. This is currently the dominant circulating strain in the United Kingdom and is associated with pharyngitis, scarlet fever and iGAS infection; demonstrating intense transmission in a school environment. 3 Global spread of M1 UK is occurring with cases reported in Australia, United States, Canada and the Netherlands. 4
pediatrics,immunology,infectious diseases
What problem does this paper attempt to address?